Immucell ICCC
NASDAQ ICCC
$10.58 +0.13 (+1.24%)
As of: Oct 21, 2026 · 12:58 PM EDT

Immucell (ICCC) Construction in Progress (2011 - 2024)

Updated

Immucell's Construction in Progress was $2.32 million in Q4 2024.

Analysis

Immucell (ICCC) Construction in Progress (2011 - 2024) Analysis & Trends

From Q4 2011 onward, Immucell has reported Construction in Progress for 20 quarters.

  • The Q4 2024 figure marks the highest quarterly Construction in Progress since Q3 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,137.42 Bn 1,106.00 Bn 19.71 Bn -
2 Johnson & Johnson 617.98 Bn 536.51 Bn 17.26 Bn -
3 AbbVie 502.80 Bn 475.92 Bn 12.70 Bn -
4 Merck 368.67 Bn 323.05 Bn 12.21 Bn -
5 Novartis Ag 298.36 Bn 262.35 Bn 11.24 Bn -
6 Astrazeneca 261.17 Bn 234.85 Bn 12.86 Bn -
7 Amgen 237.18 Bn 192.58 Bn 7.24 Bn -
8 Gilead Sciences 191.11 Bn 165.31 Bn 6.22 Bn -
9 Pfizer 169.83 Bn 116.48 Bn 10.94 Bn -
10 Immucell 95.91 Mn 73.35 Mn 2.44 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 2.32 Mn
Sep 30, 2017 17.11 Mn
Jun 30, 2017 13.32 Mn
Mar 31, 2017 7.48 Mn
Dec 31, 2016 3.69 Mn
Sep 30, 2016 1.04 Mn
Jun 30, 2016 521,811.00
Mar 31, 2016 18,751.00
Dec 31, 2015 1.08 Mn
Sep 30, 2015 738,282.00
Jun 30, 2015 646,290.00
Mar 31, 2015 530,526.00
Dec 31, 2014 1.27 Mn
Sep 30, 2014 204,253.00
Jun 30, 2014 222,510.00
Mar 31, 2014 194,449.00
Dec 31, 2013 9,600.00
Sep 30, 2013 4,370.00
Mar 31, 2013 4,137.00
Dec 31, 2011 1,331.00
API Access

Immucell Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=ICCC&period=max&api_key=YOUR_API_KEY